论文部分内容阅读
目的分析急性发作期哮喘应用孟鲁司特联合沙丁胺醇及布地奈德治疗的临床效果.方法选择120例急性发作期哮喘患者,将其随机分为研究组(60例)与对照组(60例),研究组应用孟鲁司特联合沙丁胺醇及布地奈德治疗,对照组应用布地奈德联合沙丁胺醇治疗,两组患者均给予治疗7天,对两组的疗效以及不良反应情况进行比较分析.结果两组的总有效率比较,研究组总有效率高达98.33%(59/60),对照组为86.67%(52/60),差异具有统计学意义(P<0.05);经治疗后,两组的峰值呼气流速(PEF)相比较,研究组亦高于对照组(P<0.05),两组均未见明显的不良反应情况发生.结论对于急性发作期的哮喘应用孟鲁司特联合沙丁胺醇及布地奈德治疗,其效果明显,且安全可靠,值得临床广泛推广应用.“,”]Objective: To analysis the effect of Combined application of Montelukast, Salbutamol and Budesonide for patients with asthma in acute episode. Methods: A total of 120 patients with acute episode of asthma patients were randomly divided into group (60cases) and control group (60 cases), the application LuSi meng, combined ventolin and budesonide, control application budesonide combined ventolin, two groups of patients were treated to 7 days, the two groups of curative effect and adverse reaction analysis. Results: Two groups of the total effective rate is, the team with the total effective rate reaches as high as 98.33% (59/60), and the control group was 86.67% (52/60), a statisticaly significant difference (P <0.05); After the treatment, the two groups of peak breath flow (PEF) compared to, the team also higher than that of the control group (P < 0.05), the two groups were not see obvious adverse reaction happens. Conclusions: Application of Montelukast, Salbutamol and Budesonide for acute episode of asthma, its effect is obvious, safe and reliable, and it is worth clinical extensive application.